The amendment is not yet law. It must clear the full House and Senate before becoming binding. Until then, WISeR remains active in participating states, and providers must continue complying with its requirements while processing appeals of denied claims. The specific language of the appropriations bill and any amendments from the Senate remain subject to negotiation.
Attorneys representing Medicare providers and beneficiaries should monitor the bill's progress through the full legislative process. Even if the amendment passes both chambers, CMS may attempt to continue or modify the program through alternative funding mechanisms or regulatory authority. Providers currently subject to WISeR requirements should document all denials and appeals now, as this legislative action could provide grounds for retroactive relief or class action exposure depending on how the program ultimately concludes. The outcome will signal whether Congress intends to restrict AI-assisted prior authorization more broadly across federal health programs.